Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma

European Journal of Endocrinology

Volumn 163, Issue 6, 2010, Pages 925-935

  Eller Vainicher, Cristina ^a   Morelli, Valentina ^a   Salcuni, Antonio Stefano ^b   Battista, Claudia ^b   Torlontano, Massimo ^b   Coletti, Francesca ^c   Iorio, Laura ^d   Cairoli, Elisa ^a   Beck Peccoz, Paolo ^a   Arosio, Maura ^a,c   Ambrosi, Bruno ^d   Scillitani, Alfredo ^b   Chiodini, Iacopo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOSE; DEXAMETHASONE; DIAGNOSTIC AGENT; HYDROCORTISONE;

ADRENAL INCIDENTALOMA; ADRENALECTOMY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; ADENOMA; ADRENAL TUMOR; BLOOD; CLINICAL TRIAL; EVALUATION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INCIDENTAL FINDING; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; SECRETION; URINE;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INCIDENTAL FINDINGS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 78649901089     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0602     Document Type: Article

References (39)

1. Glazer HS, Weyman PJ, Sagel SS, Levitt RG & McClennan BL. Non functioning adrenal masses: incidental discovery on computed tomography. American Journal of Roentgenology 1982 139 81-85.
2. Griffing GT. Editorial: A-I-D-S: the new endocrine epidemic. Journal of Clinical Endocrinology and Metabolism 1994 79 1530-1531. (doi:10.1210/jc.79.6. 1530)
3. Chidiac RM & Aron DC. Incidentaloma. A disease of modern technology. Endocrinology and Metabolism Clinics of North America 1997 26 233-253. (doi:10.1016/S0889-8529(05)70242-5)
4. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A & Terzolo M. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. Journal of Endocrinological Investigation 2006 29 298-302.
5. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644. (doi:10.1210/jc.85.2.637)
6. Reincke M. Subclinical Cushing's syndrome. Endocrinology and Metabolism Clinics of North America 2000 29 47-56. (doi:10.1016/S0889-8529(05)70115-8)
7. Terzolo M, Reimondo G, Bovio S & Angeli A. Subclinical Cushing's syndrome. Pituitary 2004 7 217-224. (doi:10.1007/s11102-005-4024-6)
8. Sippel RS & Chen H. Subclinical Cushing's syndrome in adrenal incidentalomas. Surgical Clinics of North America 2004 84 875-885. (doi:10.1016/j.suc.2004.01.001)
9. Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G & Angeli A. Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinology and Metabolism Clinics of North America 2005 34 423-439. (doi:10.1016/j.ecl.2005.01. 008)
10. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F & Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5301-5306. (doi:10.1210/jc.86.11.5301)
11. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G & Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 998-1003. (doi:10.1210/jc.87.3.998)
12. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S & Lombardi G. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2002 87 4872-4878. (doi:10.1210/jc.2001-011766)
13. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P & Tabarin A. Occult Cushing's syndrome in type-2 diabetes. Journal of Clinical Endocrinology and Metabolism 2003 88 5808-5813. (doi:10.1210/jc.2003-030254)
14. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G & Trischitta V. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. European Journal of Endocrinology 2005 153 837-844. (doi:10.1530/eje.1.02045) (Pubitemid 43020234)
15. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V & Scillitani A. Subclinical hypercortisolism among outpatients referred for "Osteoporosis". Annals of Internal Medicine 2007 147 541-548.
16. Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck- Peccoz P, Arosio M, Ambrosi B & Scillitani A. Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. Journal of Clinical Endocrinology and Metabolism 2009 94 3207-3214. (doi:10.1210/jc.2009-0468)
17. Tauchmanovà L, Rossi R, Nuzzo V, Del Puente A, Esposito-Del Puente A, Pizzi C, Fonderico F, Lupoli G & Lombardi G. Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. European Journal of Endocrinology 2001 145 241-247. (doi:10.1530/eje.0.1450241)
18. Rossi R, Tauchmanova L, Lucaio A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V & Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448. (doi:10.1210/jc.85.4.1440)
19. Midorikawa S, Sanada H, Hashimoto S, Suzuki T & Watanabe T. The improvement of insulin resistance in patients with adrenal incidentalomas by surgical resection. Clinical Endocrinology 2001 54 797-804. (doi:10.1046/j.1365- 2265.2001.01274.x)
20. Emral R, Uysal AR, Asik M, Gullu S, Corapcioglu D, Tonyukuk V & Erdogan G. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocrine Journal 2003 50 399-408. (doi:10.1507/endocrj.50.399)
21. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B & Salvetti A. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology 2003 148 213-219. (doi:10.1530/eje.0.1480213)
22. Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH III & Nwariaku FE. "Subclinical Cushing's syndrome" is not so subclinical: improvement after adrenalectomy in 9 patients. Surgery 2007 142 900-905. (doi:10.1016/j.surg.2007.10.001)
23. Tsuiki M, Tanabe A, Takagi S, Naruse M & Takano K. Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocrine Journal 2008 55 737-745. (doi:10.1507/endocrj. K07E-177)
24. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F & Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Annals of Surgery 2009 249 388-391. (doi:10.1097/SLA.0b013e31819a47d2)
25. Chiodini I, Morelli V, Salcuni AS, Eller Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Pellegrini F, Copetti M, Beck-Peccoz P, Arosio M, Ambrosi B, Trischitta V & Scillitani A. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2010 95 2736-2645. (doi:10.1210/jc.2009-2387)
26. Stewart PM. Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined Journal of Clinical Endocrinology and Metabolism 2010 95 2618-2620. (doi:10.1210/jc.2010-0633)
27. Tsagarakis S, Vassiliadi D & Thalassinos N. Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. Journal of Endocrinological Investigation 2006 29 471-482.
28. Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Savoca C, Viti R, Coletti F, Guglielmi G, Battista C, Iorio L, Beck-Peccoz P, Ambrosi B, Arosio M, Scillitani A & Chiodini I. Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clinical Endocrinology 2010 73 161-166. (doi:10.1111/j.1365-2265.2010.03794.x)
29. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
30. Valassi E, Swearingen B, Lee H, Nachtigall LB, Donoho DA, Klibanski A & Biller BM. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2009 94 4851-4859. (doi:10.1210/jc.2009-1500)
31. NIH State-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consensus and State-of-the-Science Statements 2002 19 1-23.
32. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003 26 (Supplement 1) S5-S20. (doi:10.2337/diacare.25.2007.S5)
33. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497. (doi:10.1001/jama.285.19.2486)
34. Vidal J. Updated review on the benefits of weight loss. International Journal of Obesity and Related Metabolic Disorders 2002 25 (Supplement 4) 25-28. (doi:10.1038/sj.ijo.0802215)
35. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanai A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosion E, Fagard R, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B & Zamorano JL. ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. Journal of Hypertension 2007 25 1105-1187. (doi:10.1097/HJH.0b013e3281fc975a)
36. Terzolo M, Bovio S, Pia A, Conton PA, Reimondo G, Dall'Asta C, Bemporad D, Angeli A, Opocher G, Mannelli M, Ambrosi B & Mantero F. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. European Journal of Endocrinology 2005 53 307-315. (doi:10.1530/eje.1.01959)
37. Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller- Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P & Chiodini I. The limited role of midnight salivary cortisol in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas. European Journal of Endocrinology 2009 160 87-92. (doi:10.1530/EJE-08-0485)
38. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA & Wieand HS. Management of the clinically inapparent adrenal mass ("incidentalomas" ). Annals of Internal Medicine 2003 138 424-429.
39. Eller-Vainicher C, Morelli V, Salcuni A, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Carnevale V, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A & Chiodini I. Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? European Journal of Endocrinology 2009 162 91-99. (doi:10.1530/EJE-09-0775)